Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
出版年份 2019 全文链接
标题
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
作者
关键词
-
出版物
Science Translational Medicine
Volume 11, Issue 509, Pages eaaw8412
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2019-09-12
DOI
10.1126/scitranslmed.aaw8412
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting the KRAS, p38α, and NF-κB in lung adenocarcinoma cancer cells: The effect of combining RNA interferences with a chemical inhibitor
- (2019) Habib Zarredar et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Human Testis Phosphoproteome Reveals Kinases as Potential Targets in Spermatogenesis and Testicular Cancer
- (2019) Judit Castillo et al. MOLECULAR & CELLULAR PROTEOMICS
- Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models
- (2019) Yves Depetter et al. INTERNATIONAL JOURNAL OF CANCER
- Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds
- (2019) Omaima M. Abdelhafez et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Genetic compensation triggered by mutant mRNA degradation
- (2019) Mohamed A. El-Brolosy et al. NATURE
- 2,4‑Di‑tert‑butylphenol, a potential HDAC6 inhibitor, induces senescence and mitotic catastrophe in human gastric adenocarcinoma AGS cells
- (2018) Yeon Woo Song et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Estimation of clinical trial success rates and related parameters
- (2018) Chi Heem Wong et al. BIOSTATISTICS
- MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway
- (2018) Bin Zeng et al. BMC CANCER
- Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells
- (2018) Begoña Cánovas et al. CANCER CELL
- Pim1 supports human colorectal cancer growth during glucose deprivation by enhancing the Warburg effect
- (2018) Meng Zhang et al. CANCER SCIENCE
- Hispidulin suppresses cell growth and metastasis by targeting PIM1 through JAK2/STAT3 signaling in colorectal cancer
- (2018) Kaili Liu et al. CANCER SCIENCE
- The Emerging Picture of CDK11: Genetic, Functional and Medicinal Aspects
- (2018) Nikolas Ferreira dos Santos Paparidis et al. CURRENT MEDICINAL CHEMISTRY
- PAC-1 and its derivative WF-210 Inhibit Angiogenesis by inhibiting VEGF/VEGFR pathway
- (2018) Fangyang Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A novel HDAC6 inhibitor exerts an anti-cancer effect by triggering cell cycle arrest and apoptosis in gastric cancer
- (2018) Jing Dong et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia
- (2018) Yusuke Tarumoto et al. MOLECULAR CELL
- Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity
- (2018) Tianxiao Wu et al. MOLECULES
- Kinase inhibitors: the road ahead
- (2018) Fleur M. Ferguson et al. NATURE REVIEWS DRUG DISCOVERY
- PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis
- (2018) Bin Zhao et al. Cell Death & Disease
- Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes
- (2018) Jasper Edgar Neggers et al. Nature Communications
- MELK expression correlates with tumor mitotic activity but is not required for cancer growth
- (2018) Christopher J Giuliano et al. eLife
- Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38α
- (2018) Ivan del Barco Barrantes et al. Stem Cell Reports
- CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression
- (2018) Xu-hong Fu et al. ACTA PHARMACOLOGICA SINICA
- p21-activated kinase 4 as a switch between caspase-8 apoptosis and NF-κB survival signals in response to TNF-α in hepatocarcinoma cells
- (2018) Qing Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress
- (2018) Changwen Zhang et al. CARCINOGENESIS
- The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction
- (2018) Chen Ye et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Preclinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma
- (2018) Renate De Smedt et al. HAEMATOLOGICA
- Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1
- (2018) Omer Faruk Karatas HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Genetic and transcriptional evolution alters cancer cell line drug response
- (2018) Uri Ben-David et al. NATURE
- A limited number of double-strand DNA breaks is sufficient to delay cell cycle progression
- (2018) Jeroen van den Berg et al. NUCLEIC ACIDS RESEARCH
- Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways
- (2018) Jinlin Cao et al. Cell Death & Disease
- The HDAC6 inhibitor C1A modulates autophagy substrates in diverse cancer cells and induces cell death
- (2018) Maciej Kaliszczak et al. BRITISH JOURNAL OF CANCER
- Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells
- (2018) Fan Yang et al. LIFE SCIENCES
- Pim1 promotes cell proliferation and regulates glycolysis via interaction with MYC in ovarian cancer
- (2018) Yong Wu et al. OncoTargets and Therapy
- Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration
- (2018) James M. McFarland et al. Nature Communications
- Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis
- (2018) Tiantao Gao et al. CANCER LETTERS
- Biochemical changes of salivary gland adenoid cystic carcinoma cells induced by SGI-1776
- (2017) Xiuxiu Hou et al. EXPERIMENTAL CELL RESEARCH
- PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells
- (2017) Amany Sayed Mawas et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK
- (2017) Ge Gao et al. MOLECULAR CANCER THERAPEUTICS
- PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β
- (2017) Rui-Fang Fan et al. Molecular Medicine Reports
- PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
- (2017) Hezhe Lu et al. NATURE
- ARID1A-mutated ovarian cancers depend on HDAC6 activity
- (2017) Benjamin G. Bitler et al. NATURE CELL BIOLOGY
- Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
- (2017) Robin M Meyers et al. NATURE GENETICS
- HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia
- (2017) Wei Xiang et al. ONCOLOGY REPORTS
- Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4
- (2017) Zhiheng Li et al. ONCOLOGY REPORTS
- p38MAPK family isoform p38α and activating transcription factor 2 are associated with the malignant phenotypes and poor prognosis of patients with ovarian adenocarcinoma
- (2017) Wan-Juan Song et al. PATHOLOGY RESEARCH AND PRACTICE
- Inhibitors of cyclin-dependent kinases as cancer therapeutics
- (2017) Steven R. Whittaker et al. PHARMACOLOGY & THERAPEUTICS
- Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis
- (2017) Haiwei Mou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The target landscape of clinical kinase drugs
- (2017) Susan Klaeger et al. SCIENCE
- Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients
- (2017) Avadhut D. Joshi et al. Oncotarget
- Tumor p38MAPK signaling enhances breast carcinoma vascularization and growth by promoting expression and deposition of pro-tumorigenic factors
- (2017) Michelle Limoge et al. Oncotarget
- Targeting the T-Lak cell originated protein kinase by OTS964 shrinks the size of power-law coded heterogeneous glioma stem cell populations
- (2017) Michiya Sugimori et al. Oncotarget
- Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map
- (2017) Ian Smith et al. PLOS BIOLOGY
- Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism
- (2017) William Putzbach et al. eLife
- CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials
- (2017) Ann Lin et al. eLife
- PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration
- (2017) Helen King et al. Scientific Reports
- Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma
- (2016) TAKUMA OHASHI et al. ANTICANCER RESEARCH
- 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer
- (2016) Carole Seidel et al. BIOCHEMICAL PHARMACOLOGY
- Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors
- (2016) Kun Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Identification of quinones as novel PIM1 kinase inhibitors
- (2016) Richard L. Schroeder et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia
- (2016) M. Bellon et al. BLOOD
- Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
- (2016) Takuma Ohashi et al. BRITISH JOURNAL OF CANCER
- HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma
- (2016) Zhihao Wang et al. CANCER LETTERS
- MicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma
- (2016) Danni Deng et al. CANCER SCIENCE
- T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer
- (2016) Y. Ikeda et al. CLINICAL CANCER RESEARCH
- Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities
- (2016) Howard S. Roth et al. CURRENT MEDICINAL CHEMISTRY
- Expression and function of PIM kinases in osteosarcoma
- (2016) Shuai Mou et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells
- (2016) Jiaqi Liu et al. Journal of Translational Medicine
- HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth
- (2016) T. R. Medler et al. MOLECULAR CANCER RESEARCH
- The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas
- (2016) J. Peh et al. MOLECULAR CANCER THERAPEUTICS
- Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma
- (2016) Amro Aboukameel et al. MOLECULAR CANCER THERAPEUTICS
- Essential role of HDAC6 in the regulation of PD-L1 in melanoma
- (2016) M. Lienlaf et al. Molecular Oncology
- CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes
- (2016) Bastiaan Evers et al. NATURE BIOTECHNOLOGY
- PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
- (2016) Dai Horiuchi et al. NATURE MEDICINE
- PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer
- (2016) Fara Brasó-Maristany et al. NATURE MEDICINE
- Phase II and phase III failures: 2013–2015
- (2016) Richard K. Harrison NATURE REVIEWS DRUG DISCOVERY
- HDAC6 promotes cell proliferation and confers resistance to gefitinib in lung adenocarcinoma
- (2016) ZHIHAO WANG et al. ONCOLOGY REPORTS
- Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma
- (2016) Teru Hideshima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PIM kinases as therapeutic targets against advanced melanoma
- (2016) Batool Shannan et al. Oncotarget
- Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon
- (2016) Juanjuan Xiao et al. Oncotarget
- PDZ-binding kinase/T-LAK cell-originated protein kinase is a target of the fucoidan from brown alga Fucus evanescens in the prevention of EGF-induced neoplastic cell transformation and colon cancer growth
- (2016) Olesia S. Vishchuk et al. Oncotarget
- Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells
- (2016) Taigo Kato et al. Oncotarget
- Glycycoumarin exerts anti-liver cancer activity by directly targeting T-LAK cell-originated protein kinase
- (2016) Xinhua Song et al. Oncotarget
- Ginsenoside Rh2 inhibiting HCT116 colon cancer cell proliferation through blocking PDZ-binding kinase/T-LAK cell-originated protein kinase
- (2016) Jianjun Yang et al. Journal of Ginseng Research
- Comparison of FDA Approved Kinase Targets to Clinical Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks
- (2016) Jingyu Xu et al. Biomed Research International
- Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation
- (2016) Max A Horlbeck et al. eLife
- PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
- (2015) Xiaoyan Dou et al. Cancer Cell International
- Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance
- (2015) M. D. Gurden et al. CANCER RESEARCH
- A Novel Cinnamon-Related Natural Product with Pim-1 Inhibitory Activity Inhibits Leukemia and Skin Cancer
- (2015) J.-E. Kim et al. CANCER RESEARCH
- Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma
- (2015) J. E. Amengual et al. CLINICAL CANCER RESEARCH
- Targeting executioner procaspase-3 with the procaspase-activating compound B-PAC-1 induces apoptosis in multiple myeloma cells
- (2015) Shadia Zaman et al. EXPERIMENTAL HEMATOLOGY
- PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma
- (2015) Bin Lei et al. HUMAN PATHOLOGY
- Overexpression of PDZ-binding kinase confers malignant phenotype in prostate cancer via the regulation of E2F1
- (2015) Jia-Hong Chen et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway
- (2015) Shou-Qing Li et al. IUBMB LIFE
- Targeting procaspase-3 with WF-208, a novel PAC-1 derivative, causes selective cancer cell apoptosis
- (2015) Fangyang Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer
- (2015) Zhuang Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clinical and biological significance of PIM1 kinase in osteosarcoma
- (2015) Yunfei Liao et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo
- (2015) Mrinal Joel et al. Molecular Cancer
- Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
- (2015) K.V. Woan et al. Molecular Oncology
- NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells
- (2015) Jih-Tung Pai et al. MOLECULES
- Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
- (2015) Junwei Shi et al. NATURE BIOTECHNOLOGY
- PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis
- (2015) YUHONG LIU et al. ONCOLOGY REPORTS
- miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6
- (2015) Xiao-chun Wang et al. ORAL ONCOLOGY
- Pyrimidinedione-mediated selective histone deacetylase 6 inhibitors with antitumor activity in colorectal cancer HCT116 cells
- (2015) Yi-Min Liu et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Aceroside VIII is a New Natural Selective HDAC6 Inhibitor that Synergistically Enhances the Anticancer Activity of HDAC Inhibitor in HT29 Cells
- (2015) Hyun-Wook Ryu et al. PLANTA MEDICA
- Histone deacetylase 6 promotes growth of glioblastoma through inhibition of SMAD2 signaling
- (2015) Shun Li et al. TUMOR BIOLOGY
- T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia
- (2015) Houda Alachkar et al. Oncotarget
- PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma
- (2015) Carmen Oi-ning Leung et al. Oncotarget
- PP2AC Level Determines Differential Programming of p38-TSC-mTOR Signaling and Therapeutic Response to p38-Targeted Therapy in Colorectal Cancer
- (2015) Yanjie Zhang et al. EBioMedicine
- Transcription Activator-Like Effector Nuclease (TALEN)-Mediated CLYBL Targeting Enables Enhanced Transgene Expression and One-Step Generation of Dual Reporter Human Induced Pluripotent Stem Cell (iPSC) and Neural Stem Cell (NSC) Lines
- (2015) Trevor Cerbini et al. PLoS One
- Down-Regulation of Deacetylase HDAC6 Inhibits the Melanoma Cell Line A375.S2 Growth through ROS-Dependent Mitochondrial Pathway
- (2015) Jun Bai et al. PLoS One
- 2-Benzazolyl-4-Piperazin-1-Ylsulfonylbenzenecarbohydroxamic Acids as Novel Selective Histone Deacetylase-6 Inhibitors with Antiproliferative Activity
- (2015) Lei Wang et al. PLoS One
- p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-κB pathway
- (2015) Nikhil Tyagi et al. Oncotarget
- HDAC6 Deacetylates Ku70 and Regulates Ku70-Bax Binding in Neuroblastoma
- (2015) Chitra Subramanian et al. NEOPLASIA
- Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
- (2015) Ulrike Weirauch et al. NEOPLASIA
- PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways
- (2014) Xueqiong Fu et al. BIOSCIENCE REPORTS
- Expression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cells
- (2014) V. Patel et al. BLOOD
- Dual Function of p38α MAPK in Colon Cancer: Suppression of Colitis-Associated Tumor Initiation but Requirement for Cancer Cell Survival
- (2014) Jalaj Gupta et al. CANCER CELL
- HDAC6 sustains growth stimulation by prolonging the activation of EGF receptor through the inhibition of rabaptin-5-mediated early endosome fusion in gastric cancer
- (2014) Se Jin Park et al. CANCER LETTERS
- Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
- (2014) Luke A. Gilbert et al. CELL
- BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
- (2014) H. Rizos et al. CLINICAL CANCER RESEARCH
- Design, synthesis, and structure–activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents
- (2014) Junjie Ma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis
- (2014) Manjola Balliu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma
- (2014) Xin Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Azaindolylsulfonamides, with a More Selective Inhibitory Effect on Histone Deacetylase 6 Activity, Exhibit Antitumor Activity in Colorectal Cancer HCT116 Cells
- (2014) Hsueh-Yun Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual Small-Molecule Targeting of Procaspase-3 Dramatically Enhances Zymogen Activation and Anticancer Activity
- (2014) Rachel C. Botham et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- PIM Kinase Inhibitor AZD1208 for Treatment of MYC-Driven Prostate Cancer
- (2014) Austin N. Kirschner et al. JNCI-Journal of the National Cancer Institute
- A novel small-molecule activator of procaspase-3 induces apoptosis in cancer cells and reduces tumor growth in human breast, liver and gallbladder cancer xenografts
- (2014) Fangyang Wang et al. Molecular Oncology
- DNA sequencing and CRISPR-Cas9 gene editing for target validation in mammalian cells
- (2014) Yegor Smurnyy et al. Nature Chemical Biology
- Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival
- (2014) Susann Herzog et al. NEURO-ONCOLOGY
- COSMIC: exploring the world's knowledge of somatic mutations in human cancer
- (2014) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- The Rational Design of Specific Peptide Inhibitor against p38α MAPK at Allosteric-Site: A Therapeutic Modality for HNSCC
- (2014) Kamaldeep Gill et al. PLoS One
- TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis
- (2014) Y. Matsuo et al. Science Translational Medicine
- MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells
- (2014) Guoqiang Zhang et al. TUMOR BIOLOGY
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- Effects of Down-regulation of HDAC6 Expression on Proliferation, Cell Cycling and Migration of Esophageal Squamous Cell Carcinoma Cells and Related Molecular Mechanisms
- (2013) Ning Li et al. Asian Pacific Journal of Cancer Prevention
- A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth
- (2013) M Kaliszczak et al. BRITISH JOURNAL OF CANCER
- HDAC6 Inhibition Restores Ciliary Expression and Decreases Tumor Growth
- (2013) S. A. Gradilone et al. CANCER RESEARCH
- T-LAK cell-originated protein kinase is essential for the proliferation of hepatocellular carcinoma SMMC-7721 cells
- (2013) Fang Chen et al. CELL BIOCHEMISTRY AND FUNCTION
- Ins and Outs of Kinase DFG Motifs
- (2013) Daniel K. Treiber et al. CHEMISTRY & BIOLOGY
- tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells
- (2013) Sergio Valente et al. ChemMedChem
- HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity
- (2013) Gang Ding et al. FEBS LETTERS
- A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
- (2013) Tint Lwin et al. JOURNAL OF CLINICAL INVESTIGATION
- HDAC6 and SIRT2 Regulate the Acetylation State and Oncogenic Activity of Mutant K-RAS
- (2013) M. H. Yang et al. MOLECULAR CANCER RESEARCH
- Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity
- (2013) R. M. Campbell et al. MOLECULAR CANCER THERAPEUTICS
- A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis
- (2013) Kantima Leelahavanichkul et al. Molecular Oncology
- Discovery of Hybrid Dual N-Acylhydrazone and Diaryl Urea Derivatives as Potent Antitumor Agents: Design, Synthesis and Cytotoxicity Evaluation
- (2013) Xin Zhai et al. MOLECULES
- BLAST: a more efficient report with usability improvements
- (2013) Grzegorz M. Boratyn et al. NUCLEIC ACIDS RESEARCH
- The HDAC Inhibitor LBH589 Induces ERK-Dependent Prometaphase Arrest in Prostate Cancer via HDAC6 Inactivation and Down-Regulation
- (2013) Mei-Jen Chuang et al. PLoS One
- Development of a histone deacetylase 6 inhibitor and its biological effects
- (2013) J.-H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- The Pak4 protein kinase is required for oncogenic transformation of MDA-MB-231 breast cancer cells
- (2013) L E Wong et al. Oncogenesis
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- p38 mitogen-activated protein kinase signaling, ERCC1 expression, and viability of lung cancer cells from never or light smoker patients
- (2012) David Planchard et al. CANCER
- Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation
- (2012) James W. Antoon et al. CANCER BIOLOGY & THERAPY
- Novel TOPK Inhibitor HI-TOPK-032 Effectively Suppresses Colon Cancer Growth
- (2012) D. J. Kim et al. CANCER RESEARCH
- Killing cells by targeting mitosis
- (2012) E Manchado et al. CELL DEATH AND DIFFERENTIATION
- Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth
- (2012) Joel A. Bergman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rational Evolution of a Novel Type of Potent and Selective Proviral Integration Site in Moloney Murine Leukemia Virus Kinase 1 (PIM1) Inhibitor from a Screening-Hit Compound
- (2012) Hirofumi Nakano et al. JOURNAL OF MEDICINAL CHEMISTRY
- HDAC6 as a target for antileukemic drugs in acute myeloid leukemia
- (2012) Björn Hackanson et al. LEUKEMIA RESEARCH
- c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomas
- (2012) Fang Hu et al. LEUKEMIA RESEARCH
- Knockdown of PAK4 or PAK1 Inhibits the Proliferation of Mutant KRAS Colon Cancer Cells Independently of RAF/MEK/ERK and PI3K/AKT Signaling
- (2012) H. Tabusa et al. MOLECULAR CANCER RESEARCH
- Differential Effects of Procaspase-3 Activating Compounds in the Induction of Cancer Cell Death
- (2012) Diana C. West et al. MOLECULAR PHARMACEUTICS
- Therapeutic opportunities for manipulating TReg cells in autoimmunity and cancer
- (2012) Harald von Boehmer et al. NATURE REVIEWS DRUG DISCOVERY
- p21-Activated kinase 4 promotes prostate cancer progression through CREB
- (2012) M-H Park et al. ONCOGENE
- Depletion of HDAC6 Enhances Cisplatin-Induced DNA Damage and Apoptosis in Non-Small Cell Lung Cancer Cells
- (2012) Lei Wang et al. PLoS One
- Inhibition of Pim–1 attenuates the proliferation and migration in nasopharyngeal carcinoma cells
- (2012) Wei Jie et al. Asian Pacific Journal of Tropical Medicine
- Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation
- (2012) Anthony B. Mak et al. Cell Reports
- A Novel Class of Small Molecule Inhibitors of HDAC6
- (2011) Elizabeth S. Inks et al. ACS Chemical Biology
- LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells
- (2011) Jian Zhang et al. CANCER LETTERS
- The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells
- (2011) D. Xu et al. CARCINOGENESIS
- Clinical and therapeutic relevance of PIM1 kinase in gastric cancer
- (2011) Benedict Yan et al. Gastric Cancer
- Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells
- (2011) Grace I. Aldana-Masangkay et al. LEUKEMIA & LYMPHOMA
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
- (2011) Thomas Force et al. NATURE REVIEWS DRUG DISCOVERY
- The proto-oncogene Pim-1 is a target of miR-33a
- (2011) M Thomas et al. ONCOGENE
- Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
- (2011) J Wang et al. ONCOGENE
- Mitosis as an anti-cancer target
- (2011) A Janssen et al. ONCOGENE
- Histone Deacetylase 6 Regulates Estrogen Receptor α in Uterine Leiomyoma
- (2011) Lin-Hung Wei et al. Reproductive Sciences
- Drug-Resistant Aurora A Mutants for Cellular Target Validation of the Small Molecule Kinase Inhibitors MLN8054 and MLN8237
- (2010) Dominic A. Sloane et al. ACS Chemical Biology
- Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition
- (2010) Carmen Blanco-Aparicio et al. CANCER LETTERS
- Discovery and Canine Preclinical Assessment of a Nontoxic Procaspase-3-Activating Compound
- (2010) Q. P. Peterson et al. CANCER RESEARCH
- p38α Is Required for Ovarian Cancer Cell Metabolism and Survival
- (2010) Antonio Matrone et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogs
- (2010) Pamela W. Lucas et al. INVESTIGATIONAL NEW DRUGS
- Cell-permeable Carboxyl-terminal p27Kip1Peptide Exhibits Anti-tumor Activity by Inhibiting Pim-1 Kinase
- (2010) Daisuke Morishita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21
- (2010) F Hu et al. ONCOGENE
- p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients
- (2010) M. K. Y. Siu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth
- (2010) B. W. Murray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor Formation
- (2009) Jian Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- Stable interference of EWS–FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target
- (2009) D Herrero-Martín et al. BRITISH JOURNAL OF CANCER
- Inhibition of the p38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells
- (2009) L. Chen et al. CANCER RESEARCH
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- p38α blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1α- to FoxO-dependent transcription
- (2009) F Chiacchiera et al. CELL DEATH AND DIFFERENTIATION
- Pim-1 expression and monoclonal antibody targeting in human leukemia cell lines
- (2009) Jie Li et al. EXPERIMENTAL HEMATOLOGY
- PAC-1 Activates Procaspase-3 in Vitro through Relief of Zinc-Mediated Inhibition
- (2009) Quinn P. Peterson et al. JOURNAL OF MOLECULAR BIOLOGY
- HDAC6 Regulates Androgen Receptor Hypersensitivity and Nuclear Localization via Modulating Hsp90 Acetylation in Castration-Resistant Prostate Cancer
- (2009) Junkui Ai et al. MOLECULAR ENDOCRINOLOGY
- Small-Molecule Activators of a Proenzyme
- (2009) D. W. Wolan et al. SCIENCE
- The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis
- (2008) Y.-S. Lee et al. CANCER RESEARCH
- Molecular Basis of Drug Resistance in Aurora Kinases
- (2008) Fiona Girdler et al. CHEMISTRY & BIOLOGY
- The kinase p38α serves cell type–specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression
- (2008) Chun Kim et al. NATURE IMMUNOLOGY
- Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer
- (2008) A. C. Kimmelman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now